LentiGuide-Neo-CTRLg1
(Plasmid
#139450)
-
PurposeLentiviral vector with non-targeting gRNA and neomycin selectable marker
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 139450 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneLentiGuide-Neo
-
Backbone manufacturerCaroline Goujon (Addgene plasmid # 139449)
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNon-targeting sgRNA inserted; resistance gene: neoR
-
gRNA/shRNA sequenceg1-CTRL 5_ -agcacgtaatgtccgtggat
-
SpeciesSynthetic
- Promoter EF-1a / U6
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BsmBI (unknown if destroyed)
- 3′ cloning site BsmBI (unknown if destroyed)
- 5′ sequencing primer n/a (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byCaroline Goujon (Addgene plasmid # 139449)
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LentiGuide-Neo-CTRLg1 was a gift from Caroline Goujon (Addgene plasmid # 139450 ; http://n2t.net/addgene:139450 ; RRID:Addgene_139450) -
For your References section:
The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry. Doyle T, Moncorge O, Bonaventure B, Pollpeter D, Lussignol M, Tauziet M, Apolonia L, Catanese MT, Goujon C, Malim MH. Nat Microbiol. 2018 Dec;3(12):1369-1376. doi: 10.1038/s41564-018-0273-9. Epub 2018 Nov 26. 10.1038/s41564-018-0273-9 [pii] PubMed 30478388